Pay in 4 interest-free payments of $5.33 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Week 37-48: approaching peak results The 48-week endpoint of the phase 2 trial represents the longest published clinical data for retatrutide
Retatrutide activates three hormone receptors (GIP, GLP-1, and glucagon) instead of one (semaglutide: GLP-1 only) or two (tirzepatide: GLP-1 + GIP)
Longer bundles unlock lower per-month rates the headline $99/month reflects the 12-month bundle on the entry-tier compounded semaglutide product
The multi-dose vial safety guide covers the contamination pathway in detail
US$ 25.95
US$ 29.05
US$ 21.95
US$ 29.20
US$ 26.30
